LexDanaLexDanabeta
Inventor

Jian Chen

Inventor
Princeton, NJ, US

Overview

50→
Patents
1999–2013
Patent span
Chemistry
Primary field (CPC C)

Patents· 50 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary
C07KPeptides23%
A61KPreparations for medical, dental or toiletry purposes19%
C12NMicroorganisms or enzymes12%
A01KAnimal husbandry9%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations7%
C07HSugars7%
G01NInvestigating or analysing materials by determining their chemical or physical properties7%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture4%
Y02PClimate change mitigation technologies in the production or processing of goods3%
PatentTitleYear
8,354,264'Polynucleotides encoding novel PCSK9 variants'20138,338,132'Nucleic acids encoding receptor for IL-17 homologous polypeptides and therapeutic uses thereof'20128,273,703'IL-17 receptor-like polypeptides and therapeutic uses thereof'20128,105,804'Polynucleotides encoding novel PCSK9 variants'20128,101,568'Peptides for inhibiting insects'20128,075,888'Methods of treatment using antibodies to IL-17 homologous polypeptides'20118,034,342'Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E'20117,846,706'PCSK9 polypeptides'20107,767,418'Polynucleotide encoding a novel TRP channel family member, LTRPC3, and splice variants thereof'20107,749,500'Antibodies to IL-17 polypeptides and therapeutic uses thereof'20107,718,770'PRO1305-polypeptides'20107,705,133'Antibodies which bind variants of the TRP channel family member, LTRPC3'20107,696,319'PRO1772 antibodies'20107,598,348'Adiponectin receptor variant, AdipoR2v2'20097,572,618'Polynucleotides encoding novel PCSK9 variants'20097,563,867'PRO4356 polypeptides'20097,541,434'Polypeptide for a TRP channel family member, TRP-PLIK2, and splice variants'20097,504,481'TRP channel family member, LTRPC3 polypeptides'20097,459,532'Variants of the TRP channel family member, LTRPC3G'20087,344,882'Polynucleotides encoding variants of the TRP channel family member, LTRPC3'20087,335,730'PRO7436 polypeptides'20087,309,771'PRO19646 polypeptides'20077,291,718'PRO1758 antibodies'20077,291,704'PRO1758 polypeptides'20077,288,632'Dropsophila tumor necrosis factor class molecule (“DmTNFv2”)'20077,285,633'Metalloprotease highly expressed in the testis, MMP-29'20077,276,578'PRO4334 polypeptides'20077,259,002'Polynucleotide encoding a novel acyl coenzyme A, monoacylglycerol acyltransferase-3 (MGAT3), and uses thereof'20077,256,267'Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01'20077,250,490'PRO1480 polypeptides'20077,247,717'Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01'20077,223,557'Polynucleotide encoding a TRP channel family member, TRP-PLIK2'20077,217,412'IL-17C related mammalian cytokine polypeptides'20077,202,056'Polynucleotides encoding a human cell surface protein with immunoglobulin folds, BGS-19'20077,186,564'Polynucleotides encoding novel cysteine proteases of the calpain superfamily, CAN-12v1 and CAN-12v2.'20077,125,962'Anti-Pro268 antibodies'20067,115,398'IL-17 homologous polypeptides and therapeutic uses thereof'20067,056,737'Polynucleotides encoding a novel glycine receptor alpha subunit expressed in the gastrointestinal tract, HGRA4, and splice variant thereof'20067,037,676'Drosophila tumor necrosis factor class molecule polynucleotides and variants thereof'20067,034,134'Polynucleotide encoding a novel metalloprotease highly expressed in the testis, MMP-29'20066,642,041'Polynucleotides encoding a novel metalloprotease, MP-1'20036,579,520'IL-17 related mammalian cytokine polypeptides (IL-17E)'20036,569,420'Human interferon-: a type I interferon'20036,569,645'IL-17 homologous polypeptides and therapeutic uses thereof'20036,299,869'Human interferon-epsilon: a type I interferon'20016,299,877'Type I interferons'20016,300,475'Interferon PRO655'20016,200,780'Human interferon-.epsilon.(IFN-.epsilon.), a type I interferon'20016,033,660'Method of treating a nervous system injury with cultured schwann cells'20005,955,420'Rse receptor activation'1999

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1999–2012Patents assigned to GENENTECH INC (26)· patent assignee history
1999–2000Based in Burlingame, CA, US· patent location history
2001Based in Plainsboro, NJ, US· patent location history
2001–2003Based in San Mateo, CA, US· patent location history
2003–2013Based in Princeton, NJ, US· patent location history
2006–2013Patents assigned to BRISTOL MYERS SQUIBB CO (20)· patent assignee history
2011–2013Patents assigned to CHEN JIAN (5)· patent assignee history
2011–2012Patents assigned to FILVAROFF ELLEN (3)· patent assignee history
2011–2012Patents assigned to GODDARD AUDREY (3)· patent assignee history
2012Based in Athens, GA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GENENTECH INC261999–2012
BRISTOL MYERS SQUIBB CO202006–2013
CHEN JIANself52011–2013
FILVAROFF ELLEN32011–2012
GODDARD AUDREY32011–2012
Locations
LocationPatentsSpan
Princeton, New Jersey, US422003–2013
Plainsboro, New Jersey, US32001
San Mateo, California, US22001–2003
Burlingame, California, US21999–2000
Athens, Georgia, US12012